Connect with us to learn more about how we can help guide the way forward

Attending the 2025 SNO Conference? Register for our symposium

Saturday, November 22, 2025 | 7:00am-8:15am 

Applications of Belay Summit™ CSF Liquid Biopsy to Inform & Manage CNS Tumors

In this session, demonstrated results and clinical applications in patient cases from Belay Summit™ 1.0 and Belay Summit™ 2.0 Comprehensive Genomic Profile will be presented. The focus will be on the interrogation of tumor-derived nucleic acids in CSF and their role in diagnosis, classification, disease monitoring, treatment selection, and clinical management for primary and metastatic CNS cancers.